Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases

Metabolic syndrome is estimated to affect more than one in five adults, and its prevalence is growing in the adult and pediatric populations. The most widely recognized metabolic risk factors are atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose. Individuals with these c...

Descripción completa

Detalles Bibliográficos
Autores principales: Monsalve, Francisco A., Pyarasani, Radha D., Delgado-Lopez, Fernando, Moore-Carrasco, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678499/
https://www.ncbi.nlm.nih.gov/pubmed/23781121
http://dx.doi.org/10.1155/2013/549627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678499/
https://www.ncbi.nlm.nih.gov/pubmed/23781121
http://dx.doi.org/10.1155/2013/549627

Ejemplares similares